Research Topics
| OWEN M contact WOLKOWITZSummaryAffiliation: University of California Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Resting leukocyte telomerase activity is elevated in major depression and predicts treatment responseO M Wolkowitz
Department of Psychiatry, University of California, San Francisco UCSF, School of Medicine, San Francisco, CA, USA
Mol Psychiatry 17:164-72. 2012..PBMC telomerase activity might reflect a novel aspect of depressive pathophysiology and might represent a novel biomarker of antidepressant responsiveness...
Serum BDNF levels before treatment predict SSRI response in depressionOwen M Wolkowitz
Department of Psychiatry, University of California, San Francisco School of Medicine, San Francisco, CA 94143, United States
Prog Neuropsychopharmacol Biol Psychiatry 35:1623-30. 2011..It is also unknown whether pre-treatment serum BDNF levels predict antidepressant response...
Depression gets old fast: do stress and depression accelerate cell aging?Owen M Wolkowitz
Department of Psychiatry, University of California School of Medicine, San Francisco, California, USA
Depress Anxiety 27:327-38. 2010....
The "steroid dementia syndrome": a possible model of human glucocorticoid neurotoxicityOwen M Wolkowitz
Department of Psychiatry, Medical Center, University of California, San Francisco, San Francisco, CA, USA
Neurocase 13:189-200. 2007..Although this syndrome is uncommon, it is consistent with evolving theories of the neurotoxic or neuroendangering potential of glucocorticoids in some situations...
Glucocorticoids. Mood, memory, and mechanismsOwen M Wolkowitz
Department of Psychiatry, University of California San Francisco UCSF School of Medicine, San Francisco, California, USA
Ann N Y Acad Sci 1179:19-40. 2009..The article concludes with a conceptual model of glucocorticoid actions in the brain that may lead to novel therapeutic opportunities...
Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress--preliminary findingsOwen M Wolkowitz
Department of Psychiatry, University of California San Francisco School of Medicine, San Francisco, California, United States of America
PLoS ONE 6:e17837. 2011..We sought to determine if leukocyte telomeres are shortened in Major Depressive Disorder (MDD), whether this is a function of lifetime depression exposure and whether this is related to putative mediators, oxidation and inflammation...
Of sound mind and body: depression, disease, and accelerated agingOwen M Wolkowitz
Department of Psychiatry, School of Medicine, University of California, San Francisco, California, USA
Dialogues Clin Neurosci 13:25-39. 2011..These factors interact in increasing the likelihood of physical disease and of accelerated aging at the cellular level. We conclude with suggestions for novel mechanism-based therapeutics based on these mediators...
Repeated psychological stress testing in stimulant-dependent patientsDebra S Harris
Drug Dependence Research Center, Langley Porter Psychiatric Institute, Department of Psychiatry, University of California, San Francisco, CA, USA
Prog Neuropsychopharmacol Biol Psychiatry 29:669-77. 2005..Although less convincing because of the heterogeneity of the subjects, they also suggest that HPA axis responsivity is not clearly linked to acute stress-induced stimulant craving or affective response...
Chronic pregnenolone effects in normal humans: attenuation of benzodiazepine-induced sedationSharon E Meieran
University of California, San Francisco School of Medicine, San Francisco, CA, USA
Psychoneuroendocrinology 29:486-500. 2004..Further larger-scale studies, utilizing a broader range of doses and experimental conditions, are warranted...
Cell aging in relation to stress arousal and cardiovascular disease risk factorsElissa S Epel
UCSF Department of Psychiatry, San Francisco, CA, USA
Psychoneuroendocrinology 31:277-87. 2006..These findings may implicate telomerase as a novel and important mediator of the effects of psychological stress on physical health and disease...
Altering cortisol level does not change the pleasurable effects of methamphetamine in humansDebra S Harris
Drug Dependence Research Center, Langley Porter Psychiatric Institute, Department of Psychiatry, University of California, San Francisco, CA 94143 0984, USA
Neuropsychopharmacology 28:1677-84. 2003..Metyrapone was associated with significant premature ventricular complexes in two subjects during methamphetamine administration and may not be safe for those who use methamphetamine...
Dynamics of telomerase activity in response to acute psychological stressElissa S Epel
Department of Psychiatry, University of California, San Francisco, 3333 Calif St, Suite 465, San Francisco, CA 94143, USA
Brain Behav Immun 24:531-9. 2010....
The "steroid dementia syndrome": an unrecognized complication of glucocorticoid treatmentOwen M Wolkowitz
University of California, San Francisco, School of Medicine, 401 Parnassus Ave, Box F 0984, San Francisco, CA 94143 0984, USA
Ann N Y Acad Sci 1032:191-4. 2004..Several clinical cases of this syndrome, with shared phenomenological and neuropsychological features, are presented here...
Double-blind antiglucocorticoid treatment in schizophrenia and schizoaffective disorder: a pilot studyElysa J Marco
University of California, Langley Porter Psychiatric Institute, San Francisco, USA
World J Biol Psychiatry 3:156-61. 2002..Further studies with larger sample sizes, more extensive endocrine assessments and longer duration of drug administration seem warranted...
Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS)Nicole Maninger
Department of Psychiatry, University of California San Francisco, School of Medicine, San Francisco 94143, USA
Front Neuroendocrinol 30:65-91. 2009..Accumulating data suggest abnormal DHEA and/or DHEAS concentrations in several neuropsychiatric conditions. The evidence that DHEA and DHEAS may be fruitful targets for pharmacotherapy in some conditions is reviewed...
Serum brain-derived neurotrophic factor predicts responses to escitalopram in chronic posttraumatic stress disorderWilliam Berger
Department of Psychiatry, University of California, San Francisco, CA, USA
Prog Neuropsychopharmacol Biol Psychiatry 34:1279-84. 2010..Some studies have found that antidepressants increase serum brain-derived neurotrophic factor (BDNF) levels in patients with major depression and the expression of BDNF mRNA in limbic structures of rats...
Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depressionFirdaus S Dhabhar
Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, Stanford, CA 94305, USA
J Psychiatr Res 43:962-9. 2009....
When blue turns to grey: do stress and depression accelerate cell aging?Owen M Wolkowitz
World J Biol Psychiatry 9:2-5. 2008
Behavioral implications of lowering cholesterol levels: a double-blind pilot studyTom Ormiston
Santa Clara Valley Medical Center, San Jose, CA 95128, USA
Psychosomatics 44:412-4. 2003..This pilot study, although limited in size, raises the possibility that cholesterol-lowering drugs are associated with mild, time-limited increases in impulsivity and with mild, time-delayed improvements in depression ratings...
Neurotransmitters, neurosteroids and neurotrophins: new models of the pathophysiology and treatment of depressionOwen M Wolkowitz
World J Biol Psychiatry 4:98-102. 2003
Benzodiazepines in schizophrenia: prefrontal cortex atrophy predicts clinical response to alprazolam augmentationWilliam W Seeley
Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, USA
World J Biol Psychiatry 3:221-4. 2002..Mechanistic considerations and suggestions for future research are discussed...
Research Grants
- Neurosteroids and acute Alcohol Intoxication in HumansOwen Wolkowitz; Fiscal Year: 2007..abstract_text> ..
- Cell Aging in Major DepressionOWEN M contact WOLKOWITZ; Fiscal Year: 2010..This in turn would yield new insights into the biology of depression and might spur the development of new treatments aimed at the molecular causes and consequences of depression. ..
